A Pilot Study Examining the Efficacy of a Support Algorithm for Commencing Patients with Type 2 Diabetes on a Basal / Prandial Insulin Regimen in the Primary Care Setting With Professional Continuous Glucose Monitoring as an Adjunct.
Phase of Trial: Phase IV
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Insulin glargine; Insulin glulisine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms INITIATION
- Sponsors Sanofi
- 31 May 2012 Status changed from not yet recruiting to recruiting as reported by Australian New Zealand Clinical Trials Registry record.
- 28 May 2012 Additional lead trial centre identified as reported by Australian New Zealand Clinical Trials Registry.
- 17 Aug 2011 New trial record